1. HOME
2. Research Insight
3. Thermo Fisher Scientific Inc., (US) and Danaher Corporation (US) are Leading Players in the Laser Capture Microdissection Market

The laser capture microdissection market is projected to reach USD 306 million by 2029 from an estimated USD 184  million in 2024, at a CAGR of 10.6% during the forecast period. The major factors driving the growth of this market include the increasing R&D funding, increasing outsourcing of laser capture microdissection related services, increase in healthcare expenditure. However, the high cost of instruments, accessories and maintenance is a major factor restraining market growth to a certain extent.

The global laser capture microdissection market is a consolidated with top players such as, Thermo Fisher Scientific Inc., (US), Danaher Corporation (US), Carl Zeiss AG (Germany), F. Hoffmann-La Roche AG (Switzerland), and Standard BioTools (US).

To know about the assumptions considered for the study download the pdf brochure

Thermo Fisher Scientific, Inc. (US)

Thermo Fisher Scientific is one of the leading players in the life science industry, with a strong market presence in more than 80 countries. The company is involved in the development, manufacturing, sales, and distribution of analytical instruments, equipment, reagents and consumables, software, and services. The company operates its business through four key segments—Laboratory Products and Biopharma Services, Life Sciences Solutions, Analytical Instruments, and Specialty Diagnostics. The company offers laser capture microdissection products through the Life Sciences Solutions business.

Thermo Fisher Scientific, Inc. (US) held the leading position in the global laser capture microdissection market in 2023. The company has maintained its leadership through its strong distribution network across Asia-Pacific, Latin America, Europe, the Middle East and Africa, and North America. It focuses on expanding its presence in the market by strategically investing in R&D to relaunch innovative and advanced products in the market. Additionally, in August 2021, Thermo Fisher Scientific launched the Arcturus Cellect Laser Capture Microdissection System, an update to the current Arcturus XT Laser Capture Microdissection Instrument which contains both IR and UV lasers, in the Q4 of 2021.

Danaher Corporation (US)

Danaher Corporation manufactures medical, industrial, and commercial products & services. The company operates through four business segments: Diagnostics, Biotechnology, Life Sciences, and Environmental & Applied Solutions. The company offers laser capture microdissection products through its Life Sciences subsidiary Leica Microsystems GmbH, a German microscope manufacturing company. It is a manufacturer of optical microscopes, equipment for the preparation of microscopic specimens and related products.

The company also focuses on acquisition, collaborations, and expansion to sustain its foothold in the market. For instance, in August 2023, Danaher Corporation acquired Abcam plc, a leading supplier of protein consumables. Abcam is to operate as a standalone operating company and brand within Danaher's Life Sciences segment, furthering Danaher's strategy to help map complex diseases and accelerate the drug discovery process using Danaher’s technology.

Carl Zeiss AG (Germany)

Carl Zeiss AG (Carl Zeiss), a subsidiary of Carl Zeiss Stiftung AG, is a medical technology company that is engaged in manufacturing and commercialization of optical and optoelectronic products. The company operates through five business segments which includes Semiconductor Manufacturing Technology, Industrial Quality & Research, Medical Technology, Consumer Markets, and Others. The company provides laser capture microdissection products through its medical technology segment. The company’s microscope systems enable users to gain new insights into biology, medicine, pharmacy, and chemistry. In addition to its wide range of high-end microscopes, the company manufactures student microscopes with minimum basic functionalities to be used at academic levels. The company has its operations in 30 countries, across EMEA, Americas, and APAC.

The company is focusing on expansion to increase its market share in the market. For instance, in April 2021, ZEISS completed construction of its new R&D, production, sales and customer service site in the US. The new ZEISS Innovation Center harnesses their technological, research and customer services strengths in one of the world’s premier technology innovation locations in North America.

F. Hoffmann-La Roche AG (Switzerland)

F. Hoffmann-La Roche AG, commonly known as Roche, is a Swiss multinational healthcare company that develops drugs and diagnostics to treat major diseases. is the fourth-largest player in the global laser capture microdissection market. The company also offers in vitro diagnostics, tissue-based cancer diagnostics, and diabetes management solutions. Roche conducts research to identify novel methods to prevent, diagnose, and treat diseases. The company operates in the laser capture microdissection market through its molecular lab sub-segment of diagnostics division.

The company offers laser capture microdissection instrument AVENIO Millisect System, earlier which is the product of AvanSci Bio. In December 2014, Roche Diagnostics, part of a diagnostics division of F. Hoffman-La Roche AG signed a deal with AvanSci Bio to buy all products associated with the high-performance microdissection of slide-mounted tissue sections. AvanSci Bio's technology includes the automated MilliSect instrument which reportedly enables a greater than 90% tumor enriched sample for molecular analysis. The system will be tested at select customer sites in 2015 as part of a broader development program for a future generation instrument.

Standard BioTools (US)

Standard BioTools previously known as Fluidigm Corp, develops, manufactures, and markets life science analytical and preparatory systems for mass cytometry, high-throughput genomics, and single-cell genomics and proteomics markets.

The laser capture microdissection product offered by the company is used in both proteomics and genomics studies. The company distributes its systems through a direct sales force and support organizations across North America, Europe and Asia-Pacific, and also, through a network of distributors across Latin America, Europe, the Middle East and Asia-Pacific. The company is focusing on investment and funding to build a strong portfolio in the market. For instance, in April 2022, Fluidigm Corporation announced the closing of the previously announced strategic capital infusion from leading life sciences investors Casdin Capital, LLC, and Viking Global Investors LP. Fluidigm has been renamed Standard BioTools Inc.

Related Reports:

Laser Capture Microdissection Market by Product (Instruments, Consumables, Software, Services), System Type (Ultraviolet, Infrared, Immunofluorescence), Application (R&D (Molecular Biology, Cell Biology, Forensics), Diagnostics) - Global Forecast to 2029

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]